Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
7(44%)
Results Posted
80%(4 trials)
Terminated
2(13%)

Phase Distribution

Ph phase_3
1
6%
Ph phase_2
1
6%
Ph phase_4
2
13%
Ph early_phase_1
1
6%
Ph not_applicable
11
69%

Phase Distribution

1

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution16 total trials
Early Phase 1First-in-human
1(6.3%)
Phase 2Efficacy & side effects
1(6.3%)
Phase 3Large-scale testing
1(6.3%)
Phase 4Post-market surveillance
2(12.5%)
N/ANon-phased studies
11(68.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

7

trials recruiting

Total Trials

16

all time

Status Distribution
Active(7)
Completed(5)
Terminated(3)
Other(1)

Detailed Status

Active, not recruiting6
Completed5
Terminated2
Recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
7
Success Rate
71.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (6.3%)
Phase 21 (6.3%)
Phase 31 (6.3%)
Phase 42 (12.5%)
N/A11 (68.8%)

Trials by Status

recruiting16%
unknown16%
withdrawn16%
terminated213%
active_not_recruiting638%
completed531%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT05051345Not Applicable

Increasing Access to Smoking Cessation and Smoke Free Home Services for Low-Income Pregnant Women in Northeast Texas

Active Not Recruiting
NCT02271919Phase 4

Varenicline and Combined NRT for Smoking Cessation

Active Not Recruiting
NCT05044546Not Applicable

A Behavioral Activation Prenatal and Postpartum Intervention for Depressed Pregnant Smokers

Active Not Recruiting
NCT01915810Not Applicable

Physical Activity in Promoting Smoking Cessation in African Americans

Active Not Recruiting
NCT04604509Phase 4

Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial

Recruiting
NCT04340531Not Applicable

Effectiveness of a Multi-Level Smoking Cessation Program for High-Risk Women in Rural Communities

Active Not Recruiting
NCT04694846Not Applicable

Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use

Completed
NCT04200534Early Phase 1

Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)

Active Not Recruiting
NCT02591433Not Applicable

JeffQuit Group Therapy Program for Smoking Cessation in Patients With a History of Cancer

Withdrawn
NCT03808818Not Applicable

Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices

Completed
NCT06745154Not Applicable

Evaluating the Impact of Quitting Using Executive Function Strategy Training (QUEST) on Smoking Cessation in Homeless Young Adult Smokers

Completed
NCT03722966Phase 2

Effectiveness of Combination Varenicline and Oral Nicotine Replacement Therapy (COMBO)

Terminated
NCT00948129Not Applicable

Mobile Smoking Cessation Intervention in Enhancing Cancer Outreach in Low-Income Adult Smokers

Completed
NCT02856581Phase 3

Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes

Terminated
NCT03135782Not Applicable

Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy

Completed
NCT02103868Not Applicable

Medium Vs Low Intensity Intervention in Tobacco Cessation and Control in Zari Workers

Unknown

All 16 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
16